Petrol price cut by Rs 1.82/litre; diesel rate hiked by 50p

Feb 28: For 30-year-old Shabana Parveen, it was nothing sort of a miracle — giving birth to a healthy baby boy after surviving a brutal attack by a mob who kicked and assaulted her and her husband in northeast Delhi's Karawal Nagar.

Their home set afire by the mob, Ms Parveen's family is now pinning their hopes on the newborn who they called a "miracle baby".

Ms Parveen, her husband, two kids and mother-in-law were sleeping inside the house on Monday night when a mob barged into their house.

Narrating their ordeal, Ms Parveen's mother-in-law Nashima told PTI, "They hurled religious slurs, beat up my son. Some of them even kicked my daughter-in-law in the abdomen...as I went to protect her they came charging at me... We thought we would not survive that night. But with God's grace we somehow managed to escape from the clutches of the rioters."

"We rushed Parveen to a nearby hospital but doctors there asked us to go to Al-hind Hospital where she delivered a baby boy on Wednesday," she added.

Despite having lost their home for over two decades and all belongings, her family has overcome the initial shock and are now overjoyed with the birth of the "miracle baby".

Ms Nashima said she had no clue where the family would go after Ms Parveen was discharged from the hospital.

"It's all gone there. Nothing left. Maybe, we will go to some relative's place and see how we can re-build our life," she said.

Ali, 6, who held his one-day-old brother, caressing his forehead, said, "I will take care of him forever and save him from every ill."

The violence over the amended citizenship law in northeast Delhi has claimed 38 lives so far and left over 200 people injured. Frenzied mobs torched houses, shops, vehicles, a petrol pump and pelted stones at locals and police personnel.

Jaffrabad, Maujpur, Babarpur, Yamuna Vihar, Bhajanpura, Chand Bagh and Shiv Vihar are among the areas mainly affected by the clashes.

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

New Delhi, Jun 9: BJP leader Jyotiraditya Scindia and his mother Madhavi Raje Scindia have tested positive for COVID-19 and are currently undergoing treatment in a Delhi hospital, India Today reported on Tuesday.

They were admitted on Monday to Max Super Specialty Hospital, Saket, after the two complained of throat irritation and fever.

"Not so good news: @JM_Scindia and his mother have tested positive for corona, The former Cong turned BJP leader from MP has been admitted to hospital.. Wish him a speedy recovery!" tweeted Rajdeep Sardesai, consulting editor at the India Today group.

Breaking now: Not so good news: @JM_Scindia and his mother have tested positive for corona, The former Cong turned BJP leader from MP has been admitted to hospital.. Wish him a speedy recovery!  @IndiaToday

— Rajdeep Sardesai (@sardesairajdeep) June 9, 2020

Scindia, former Congress MP from Guna constituency in Madhya Pradesh, quit the party and joined BJP last March. Scindia, who was once Minister of State with independent charge for Power, is the BJP candidate for the upcoming Rajya Sabha elections from Madhya Pradesh.